Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

EMA Reviews GSK/Vir’s COVID-19 Antibody To Support Early Use By Member States

Apr 16 2021

• By Vibha Sharma

EU - Covid-19 Coronavirus Waving Flag — EMA Reviews Can Support Early National Decision-Making On COVID-19 Medicines • Source: Shutterstock

Related Content

Diurnal Renames Orphan Drug As Efmody, Expecting EU-Wide Approval

Mar 26 2021

EMA Endorses Use Of Dexamethasone In COVID-19

Sep 18 2020

Coronavirus Notebook: EU Moots Emergency Use Authorization Scheme For Vaccines, Janssen Product Up For 11 March Approval

Mar 03 2021

Vir/GSK Move Lead Coronavirus Antibody Into Phase III

Oct 07 2020

Coronavirus Notebook: AZ Vaccine Suspended In Some European Countries, Janssen’s Vaccine Approved In EU

Mar 12 2021

Related Companies

GSK plc

Vir Biotechnology, Inc.

Eli Lilly and Company

Regeneron Pharmaceuticals, Inc.

Roche Holding AG

Celltrion, Inc.

Additional Topics

Europe Coronavirus COVID-19 Review Pathway Drug Review Regulation BioPharmaceutical

More from Review Pathways

More from Pathways & Standards

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window